The PASADENA (parahydrogen and synthesis allow dramatically enhanced nuclear alignment) is a new generation of ultra-sensitive, ultra-fast in vivo MR imaging techniques that we will now optimize for use in oncology. An advantage of this technique is the increase in signal to noise (over 10,000 fold), which overcomes previous sensitivity limitations of MRI and the persistence of polarization through chemical reactions, allowing sub-second MR spectroscopy examinations with similar sensitivity enhancement. In a close collaboration between our Laboratory at HMRI and Professor Weitekamp's Group at California Institute of Technology, we propose to address five central issues, in two phases, necessary for successful introduction of Clinical Trials of PASADENA molecular brain imaging:
R21 Specific Aims : (1) Develop novel carbon (and nitrogen) spin labels as in vivo PASADENA imaging reagents. (2) Capture maximum MR signal by optimizing spin-physics and polarizer design. (3) Create sub-second in vivo 13C and 15N animal and human imaging, spectroscopy and chemical mapping sequences at 4.7 Tesla (Bruker-Paravision) and 1.5T GE LX clinical MR scanners. (4) Demonstrate efficacy of PASADENA in normal in vivo brain and in an animal model of brain tumor. Then R33 Specific Aim: (5) Demonstrate the superiority of several PASADENA contrast agents in defining tumor growth, heterogeneity, angiogenesis and prediction of a positive response to therapy, when compared to conventional MRI, 1H MRS and 1-13C glucose MRS in vivo. Adaptation of experimental procedures, including collaborations with other Academic Institutions, with Industry, Good Manufacturing Practices, toxicity testing and submission of FDA- IND applications for clinical trials will be conducted during R33 to accelerating clinical acceptance of this novel technique. Milestones are provided for achieving each of these goals. Sub-second imaging techniques developed in this proposal will have far-reaching impact on all areas of oncology in which current imaging technologies are insufficiently precise or insensitive to early diagnosis. Parahydrogen induced polarization, which involve no harmful radiation and can be performed at lower magnetic fields, will reduce the need for ever more powerful and costly ultra- high field MRI scanner currently being constructed, thereby bringing MR imaging to third world and other societies that are currently excluded from modern health care on grounds of cost. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21CA118509-02
Application #
7295710
Study Section
Special Emphasis Panel (ZRG1-SBIB-J (01))
Program Officer
Zhang, Huiming
Project Start
2006-09-27
Project End
2009-08-31
Budget Start
2007-09-01
Budget End
2009-08-31
Support Year
2
Fiscal Year
2007
Total Cost
$119,669
Indirect Cost
Name
Huntington Medical Research Institutes
Department
Type
DUNS #
077978898
City
Pasadena
State
CA
Country
United States
Zip Code
91101
Salzillo, Travis C; Hu, Jingzhe; Nguyen, Linda et al. (2016) Interrogating Metabolism in Brain Cancer. Magn Reson Imaging Clin N Am 24:687-703
Zacharias, Niki M; McCullough, Christopher R; Wagner, Shawn et al. (2016) Towards Real-time Metabolic Profiling of Cancer with Hyperpolarized Succinate. J Mol Imaging Dyn 6:
Cassidy, M C; Chan, H R; Ross, B D et al. (2013) In vivo magnetic resonance imaging of hyperpolarized silicon particles. Nat Nanotechnol 8:363-8
Lingwood, Mark D; Siaw, Ting Ann; Sailasuta, Napapon et al. (2012) Hyperpolarized water as an MR imaging contrast agent: feasibility of in vivo imaging in a rat model. Radiology 265:418-25
Zacharias, Niki M; Chan, Henry R; Sailasuta, Napapon et al. (2012) Real-time molecular imaging of tricarboxylic acid cycle metabolism in vivo by hyperpolarized 1-(13)C diethyl succinate. J Am Chem Soc 134:934-43
Ross, Brian; Tran, Thao; Bhattacharya, Pratip et al. (2011) Application of NMR spectroscopy in medicinal chemistry and drug discovery. Curr Top Med Chem 11:93-114
Bhattacharya, Pratip; Chekmenev, Eduard Y; Reynolds, Wanda F et al. (2011) Parahydrogen-induced polarization (PHIP) hyperpolarized MR receptor imaging in vivo: a pilot study of 13C imaging of atheroma in mice. NMR Biomed 24:1023-8
Ross, B D; Bhattacharya, P; Wagner, S et al. (2010) Hyperpolarized MR imaging: neurologic applications of hyperpolarized metabolism. AJNR Am J Neuroradiol 31:24-33
Perman, William H; Bhattacharya, Pratip; Leupold, Jochen et al. (2010) Fast volumetric spatial-spectral MR imaging of hyperpolarized 13C-labeled compounds using multiple echo 3D bSSFP. Magn Reson Imaging 28:459-65
Lingwood, Mark D; Siaw, Ting Ann; Sailasuta, Napapon et al. (2010) Continuous flow Overhauser dynamic nuclear polarization of water in the fringe field of a clinical magnetic resonance imaging system for authentic image contrast. J Magn Reson 205:247-54

Showing the most recent 10 out of 17 publications